account_balance
Investment manager · 13F filer · SEC CIK 1121404
Sanofi
Reported value$534Mas of Jun 30, 2026
Positions10 2 new, 1 sold out
Top 10 weight100%MGTX alone is 31%
FiledJul 2828 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
MGTX
MeiraGTx Holdings plc
30.9%
INBX
Inhibrx Biosciences, Inc.
20.5%
NVAX
Novavax
12.1%
ANAB
AnaptysBio
10.4%
ODTX
Odyssey Therapeutics Inc.
7.0%New
AGMB
Agomab Therapeutics NV
6.8%
MPLT
MapLight Therapeutics Inc.
6.1%
TRAX
First Tracks Biotherapeutics Inc.
3.1%New
IMRX
Immuneering Corp
2.5%
QTTB
0.6%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed